ENHO and obesity due to melanocortin 4 receptor deficiency: Although it is not yet well understood how adropin levels decrease in the presence of obesity, it has been shown that adropin-knockout mice exhibit development of insulin resistance and metabolic dysregulation, and treatment with exogenous adropin, may improve these conditions [15].